Related Experiment Video
Updated: May 11, 2026
07:46
Experimental Endocarditis Model of Methicillin Resistant Staphylococcus aureus (MRSA) in Rat
Published on: June 4, 2012
Prosthetic valve endocarditis: clinical findings and management
European Heart Journal
|October 1, 1984
Summary
Prosthetic valve endocarditis (PVE) affects 1.4% early and 1.5% late after surgery. Surgical treatment significantly improves survival rates compared to conservative management for PVE patients.
Area of Science:
- Cardiology
- Infectious Diseases
- Surgical Innovation
Background:
- Prosthetic valve endocarditis (PVE) is a serious complication following prosthetic heart valve implantation.
- Understanding the incidence, causative agents, and clinical manifestations of PVE is crucial for patient outcomes.
Purpose of the Study:
- To investigate the incidence, microbiology, clinical presentation, and treatment outcomes of prosthetic valve endocarditis.
- To compare survival rates between conservative and surgical management strategies for PVE.
Main Methods:
- Retrospective analysis of 46 patients diagnosed with PVE out of 2163 patients with prosthetic heart valves.
- Microbiological analysis to identify causative pathogens.
- Echocardiographic and fluoroscopic assessments for valve dysfunction.
- Comparison of survival rates based on treatment modality (conservative vs. medical plus surgical).
Main Results:
- Cumulative PVE rates were 1.4% early and 1.5% between 60 days and 10 years post-surgery.
- Staphylococci (37%), streptococci (20%), and Gram-negative species (13%) were common pathogens; fungi (9%) and mixed infections (21%) also noted.
- Early PVE showed a higher incidence of staphylococci, Gram-negative pathogens, and fungi.
- Surgical intervention significantly improved 6-month survival (66%) versus conservative treatment (31%) and long-term survival (51% vs. 15%).
- Factors predicting worse prognosis included heart failure, persistent sepsis, septic embolism, and renal failure.
Conclusions:
- Prosthetic valve endocarditis requires prompt diagnosis and management.
- Surgical treatment offers a significantly better prognosis than conservative management for PVE.
- Early valve re-replacement demonstrates a more favorable outcome in specific patient subgroups.
Related Concept Videos
01:22Mitral Valve Prolapse II: Assessment and Management
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.
01:26Mitral Stenosis III: Medical Management
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
01:25Endocarditis I: Introduction
Introduction:Endocarditis is the infection of the endocardium, the inner lining of the heart and its valves. When the heart muscle is involved, the condition is termed myocarditis, while an infection of the outer lining is called pericarditis. Infective endocarditis (IE) primarily affects the endocardium, where pathogens adhere to the valves or lining, forming vegetation that can lead to severe complications. Infective endocarditis occurs when microorganisms, usually bacteria from other body...
01:25Endocarditis II: Clinical Features of Infective Endocarditis
Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
01:18Endocarditis III: Medical Management
Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
01:29Endocarditis IV: Nursing Management
Infective endocarditis (IE) is a chronic infection of the heart's endocardium, primarily affecting the heart valves. A detailed nursing assessment for a patient with IE involves collecting subjective and objective data to ensure an accurate diagnosis and timely intervention.Subjective DataThe nurse gathers information about the patient's symptoms and complaints during the subjective assessment. Patients with infective endocarditis often report non-specific symptoms that can mimic other...